Atelvia

Osteoporosis, Malignant Neoplasms, Postmenopause + 3 more
Treatment
5 FDA approvals
20 Active Studies for Atelvia

What is Atelvia

Risedronic acidThe Generic name of this drug
Treatment SummaryRisedronic acid is a medication used to prevent bone loss and the weakening of bones caused by conditions such as osteoporosis and Paget’s disease. It is a type of bisphosphonate, a form of drug that works by blocking the removal of bone cells.
Actonelis the brand name
image of different drug pills on a surface
Atelvia Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Actonel
Risedronic acid
1998
61

Approved as Treatment by the FDA

Risedronic acid, also called Actonel, is approved by the FDA for 5 uses including Therapeutic procedure and Bone and Bones .
Therapeutic procedure
Bone and Bones
Used to treat increased bone mass in combination with Calcium
Paget’s Disease
Osteoporosis
Used to treat Osteoporosis in combination with Calcium
Postmenopause

Effectiveness

How Atelvia Affects PatientsRisedronate is a medicine that helps prevent bones from being broken down by blocking the activity of cells called osteoclasts.
How Atelvia works in the bodyRisedronatic acid binds to the bones and stops cells that break down bones, called osteoclasts, from doing their job. It does this by entering the cells, becoming acidic, and then inhibiting an enzyme called farnesyl pyrophosphate synthase. This stops the osteoclast from breaking down the bones, which decreases bone resorption.

When to interrupt dosage

The proposed dose of Atelvia is contingent upon the recognized condition, including Therapeutic procedure, Malignant Neoplasms and Postmenopause. The measure fluctuates as per the technique of delivery, as detailed in the table beneath.
Condition
Dosage
Administration
Bone and Bones
30.0 mg, , 5.0 mg, 35.0 mg, 150.0 mg, 75.0 mg, 129.0 mg, 4.9 mg, 30.1 mg, 64.5 mg, 4.3 mg, 25.8 mg
Oral, , Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Granule, effervescent; Kit; Tablet, Granule, effervescent; Kit; Tablet - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Delayed Release, Tablet, Delayed Release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit
Osteoporosis
30.0 mg, , 5.0 mg, 35.0 mg, 150.0 mg, 75.0 mg, 129.0 mg, 4.9 mg, 30.1 mg, 64.5 mg, 4.3 mg, 25.8 mg
Oral, , Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Granule, effervescent; Kit; Tablet, Granule, effervescent; Kit; Tablet - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Delayed Release, Tablet, Delayed Release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit
Malignant Neoplasms
30.0 mg, , 5.0 mg, 35.0 mg, 150.0 mg, 75.0 mg, 129.0 mg, 4.9 mg, 30.1 mg, 64.5 mg, 4.3 mg, 25.8 mg
Oral, , Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Granule, effervescent; Kit; Tablet, Granule, effervescent; Kit; Tablet - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Delayed Release, Tablet, Delayed Release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit
Postmenopause
30.0 mg, , 5.0 mg, 35.0 mg, 150.0 mg, 75.0 mg, 129.0 mg, 4.9 mg, 30.1 mg, 64.5 mg, 4.3 mg, 25.8 mg
Oral, , Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Granule, effervescent; Kit; Tablet, Granule, effervescent; Kit; Tablet - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Delayed Release, Tablet, Delayed Release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit
Therapeutic procedure
30.0 mg, , 5.0 mg, 35.0 mg, 150.0 mg, 75.0 mg, 129.0 mg, 4.9 mg, 30.1 mg, 64.5 mg, 4.3 mg, 25.8 mg
Oral, , Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Granule, effervescent; Kit; Tablet, Granule, effervescent; Kit; Tablet - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Delayed Release, Tablet, Delayed Release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit
Paget’s Disease
30.0 mg, , 5.0 mg, 35.0 mg, 150.0 mg, 75.0 mg, 129.0 mg, 4.9 mg, 30.1 mg, 64.5 mg, 4.3 mg, 25.8 mg
Oral, , Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Granule, effervescent; Kit; Tablet, Granule, effervescent; Kit; Tablet - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, Delayed Release, Tablet, Delayed Release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit

Warnings

Atelvia has three contraindications, so it ought not be administered when encountering any of the circumstances outlined in the following table.Atelvia Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Risedronic Acid may interact with Pulse Frequency
Hypocalcemia
Do Not Combine
Postural Orthostatic Tachycardia Syndrome
Do Not Combine
There are 20 known major drug interactions with Atelvia.
Common Atelvia Drug Interactions
Drug Name
Risk Level
Description
Etidronic acid
Minor
The risk or severity of adverse effects can be increased when Risedronic acid is combined with Etidronic acid.
Incadronic acid
Minor
The risk or severity of adverse effects can be increased when Risedronic acid is combined with Incadronic acid.
Tiludronic acid
Minor
The risk or severity of adverse effects can be increased when Risedronic acid is combined with Tiludronic acid.
Acipimox
Moderate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Acipimox.
Aluminium clofibrate
Moderate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Aluminium clofibrate.
Atelvia Toxicity & Overdose RiskTen percent of people taking this drug have reported experiencing back pain, joint pain, stomach pain, and indigestion. Other rare side effects include swelling of the face, skin rashes, eye irritation, and inflammation of the uvea. If someone takes too much of this drug, they may have reduced levels of calcium and phosphorus in their blood. Treatment options include drinking milk or taking antacids to bind the drug and reduce absorption. In more serious cases, a doctor may need to give the patient their stomach contents or intravenous calcium. A single overdose of this drug in rats was found to be 320 to 620 times the

Atelvia Novel Uses: Which Conditions Have a Clinical Trial Featuring Atelvia?

Fifty active trials are being conducted to assess the potential of Atelvia to treat Paget's Disease, Postmenopause and Malignant Neoplasms.
Condition
Clinical Trials
Trial Phases
Postmenopause
7 Actively Recruiting
Phase 2, Not Applicable
Therapeutic procedure
0 Actively Recruiting
Paget’s Disease
0 Actively Recruiting
Bone and Bones
0 Actively Recruiting
Malignant Neoplasms
0 Actively Recruiting
Osteoporosis
32 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3

Atelvia Reviews: What are patients saying about Atelvia?

5Patient Review
11/10/2014
Atelvia for Decreased Bone Mass Following Menopause
I've been taking Atelvia for over a year and it's shown significant improvements in my condition with no negative side effects that I've experienced. My doctor is happy to keep me on the medication as long as they deem it safe, and I'm very content with the results.
5Patient Review
3/27/2015
Atelvia for Osteoporosis
This medication has been incredibly effective for me. I used to have to give myself a shot every day for two years with no improvement, but this drug has really helped.
4.7Patient Review
10/8/2014
Atelvia for Osteoporosis
I found this much easier to take than Actonel, and I've been taking it for years without any side effects. In most areas, it seems to have kept osteopenia at bay; however, in some areas it has progressed to osteoporosis. Overall, though, it did not improve my condition but prevented it from getting worse in most places.
4Patient Review
9/22/2014
Atelvia for Osteoporosis
I took Forteo to build up my bones and Atelvia to secure the gain (15%). It has been very effective over 3 years. I am 84 years old.
3Patient Review
12/6/2013
Atelvia for Decreased Bone Mass Following Menopause
I was experiencing pain in my joints.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about atelvia

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the side effects of Atelvia?

"The individual may experience stomach pain or discomfort, nausea, vomiting, flu-like symptoms, back pain, muscle pain, diarrhea, or constipation."

Answered by AI

How often do you take Atelvia?

"Atelvia may be used to treat osteoporosis in postmenopausal women. It is a delayed-release tablet that is taken once a week."

Answered by AI

What is Atelvia used for?

"Atelvia is a prescription medication used to treat osteoporosis in postmenopausal women. The longevity of Atelvia's efficacy is unknown. You should consult your physician periodically to see if Atelvia is still an appropriate medication for you."

Answered by AI

How long can you take Atelvia?

"Do as your doctor says when taking Atelvia. This includes following directions on the prescription label and reading all medication guides or instruction sheets. Your doctor may sometimes change your dose of the medication. Risedronate is commonly only taken for 3 to 5 years."

Answered by AI

Clinical Trials for Atelvia

Have you considered Atelvia clinical trials? We made a collection of clinical trials featuring Atelvia, we think they might fit your search criteria.
Have you considered Atelvia clinical trials? We made a collection of clinical trials featuring Atelvia, we think they might fit your search criteria.
Have you considered Atelvia clinical trials? We made a collection of clinical trials featuring Atelvia, we think they might fit your search criteria.